litlas
ログインアカウント作成

Christoph Huber

1983–2026 年に発表

別表記
CHRISTOPH HUBER
119
論文数
23,322
被引用数
83
h 指数
103
i10 指数

被引用数

Christoph Huber の年別被引用数1984 年: 被引用 2 件1986 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 4 件1989 年: 被引用 7 件1990 年: 被引用 7 件1991 年: 被引用 6 件1992 年: 被引用 7 件1993 年: 被引用 8 件1994 年: 被引用 17 件1995 年: 被引用 11 件1996 年: 被引用 17 件1997 年: 被引用 19 件1998 年: 被引用 23 件1999 年: 被引用 28 件2000 年: 被引用 35 件2001 年: 被引用 33 件2002 年: 被引用 40 件2003 年: 被引用 81 件2004 年: 被引用 51 件2005 年: 被引用 80 件2006 年: 被引用 76 件2007 年: 被引用 62 件2008 年: 被引用 61 件2009 年: 被引用 76 件2010 年: 被引用 94 件2011 年: 被引用 85 件2012 年: 被引用 142 件2013 年: 被引用 163 件2014 年: 被引用 178 件2015 年: 被引用 182 件2016 年: 被引用 270 件2017 年: 被引用 283 件2018 年: 被引用 365 件2019 年: 被引用 877 件2020 年: 被引用 1,115 件2021 年: 被引用 1,116 件2022 年: 被引用 962 件2023 年: 被引用 866 件2024 年: 被引用 1,090 件2025 年: 被引用 618 件2026 年: 被引用 21 件1985 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,778 件、この内訳の 25.4%中国: 引用元論文 1,428 件、この内訳の 13.1%ドイツ: 引用元論文 943 件、この内訳の 8.6%イギリス: 引用元論文 505 件、この内訳の 4.6%イタリア: 引用元論文 422 件、この内訳の 3.9%フランス: 引用元論文 399 件、この内訳の 3.6%スイス: 引用元論文 388 件、この内訳の 3.5%オランダ: 引用元論文 372 件、この内訳の 3.4%日本: 引用元論文 365 件、この内訳の 3.3%カナダ: 引用元論文 336 件、この内訳の 3.1%スペイン: 引用元論文 271 件、この内訳の 2.5%オーストラリア: 引用元論文 250 件、この内訳の 2.3%
0%25.4%その他 22.7%

機関

分野

  • Medicine44%
  • Immunology and Microbiology24.8%
  • Biochemistry, Genetics and Molecular Biology23.3%
  • Engineering3%
  • Neuroscience2.5%
  • Materials Science0.8%
  • その他1.6%

トピック

  • Immunotherapy and Immune Responses13.1%
  • Cancer Immunotherapy and Biomarkers7.8%
  • RNA Interference and Gene Delivery5.8%
  • CAR-T cell therapy research5.3%
  • Immune Cell Function and Interaction3.9%
  • vaccines and immunoinformatics approaches3%
  • その他61.1%

共著者

全論文

検索で開く
  1. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

    著者: Uğur Şahin, Evelyna Derhovanessian, Matthias Miller, Björn‐Philipp Kloke, Petra Simon, Martin Löwer, Valesca Bukur, Arbel D. Tadmor, Ulrich Luxemburger, Barbara Schrörs, Tana Omokoko, Mathias Vormehr, Christian Albrecht, Anna Paruzynski, Andreas N. Kuhn, Janina Buck, Sandra Heesch, Katharina Schreeb, Felicitas Müller, Inga Ortseifer, Isabel Vogler, Eva Godehardt, Sebastian Attig, Richard Rae, Andrea Breitkreuz, Claudia Tolliver, M Suchan, Goran Martic, Alexander Hohberger, Patrick Sorn, Jan Diekmann, Janko Ciesla, Olga Waksmann, Alexandra-Kemmer Brück, Meike Witt, Martina Zillgen, Andrée Rothermel, Barbara Kasemann, David Langer, Stefanie Bolte, Mustafa Diken, Sebastian Kreiter, Romina Nemecek, Christoffer Gebhardt, Stephan Grabbe, Christoph Höller, Jochen Utikal, Christoph Huber, Carmen Loquai, Özlem Türeci - Nature 2017 被引用: 2,501

  2. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

    著者: Lena M. Kranz, Mustafa Diken, Heinrich Haas, Sebastian Kreiter, Carmen Loquai, Kerstin C. Reuter, Martin Meng, Daniel Fritz, Fulvia Vascotto, Hossam Hefesha, Christian Grunwitz, Mathias Vormehr, Yves Hüsemann, Abderraouf Selmi, Andreas N. Kuhn, Janina Buck, Evelyna Derhovanessian, Richard Rae, Sebastian Attig, Jan Diekmann, Robert A. Jabulowsky, Sandra Heesch, Jessica C. Hassel, Peter Langguth, Stephan Grabbe, Christoph Huber, Özlem Türeci, Uğur Şahin - Nature 2016 被引用: 1,763

  3. An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma

    著者: Uğur Şahin, Petra Oehm, Evelyna Derhovanessian, Robert A. Jabulowsky, Mathias Vormehr, Maike Gold, Daniel Maurus, Doreen Schwarck-Kokarakis, Andreas N. Kuhn, Tana Omokoko, Lena M. Kranz, Mustafa Diken, Sebastian Kreiter, Heinrich Haas, Sebastian Attig, Richard Rae, Katarina Ćuk, Alexandra Kemmer-Brück, Andrea Breitkreuz, Claudia Tolliver, Janina Caspar, Juliane Quinkhardt, Lisa Hebich, Malte Stein, Alexander Hohberger, Isabel Vogler, Inga Liebig, Stephanie Renken, Julian Sikorski, Melanie Leierer, Verena Müller, Heidrun Mitzel-Rink, Matthias Miederer, Christoph Huber, Stephan Grabbe, Jochen Utikal, Andreas Pinter, Roland Kaufmann, Jessica C. Hassel, Carmen Loquai, Özlem Türeci - Nature 2020 被引用: 1,043

  4. Actively personalized vaccination trial for newly diagnosed glioblastoma

    著者: Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel, Valesca Bukur, Stefan Stevanović, Cécile Gouttefangeas, Michael Platten, Ghazaleh Tabatabai, Valérie Dutoit, Sjoerd H. van der Burg, Per thor Straten, Francisco Martínez‐Ricarte, Berta Ponsati, Hideho Okada, Ulrik Lassen, Arie Admon, Christian H. Ottensmeier, Alexander Ulges, Sebastian Kreiter, Andreas von Deimling, Marco Skardelly, Denis Migliorini, Judith R. Kroep, Manja Idorn, Jordi Rodón, Jordi Piró, Hans Skovgaard Poulsen, Bracha Shraibman, Katy J. McCann, Regina Mendrzyk, Martin Löwer, Monika Stieglbauer, Cedrik M. Britten, David Capper, Marij J.P. Welters, Juan Sahuquillo, Katharina Kiesel, Evelyna Derhovanessian, Elisa Rusch, Lukas Bunse, Colette Song, Sandra Heesch, Claudia Wagner, Alexandra Kemmer-Brück, Jörg Ludwig, John C. Castle, Oliver Schoor, Arbel D. Tadmor, Edward Green, Jens Fritsche, Miriam Meyer, Nina N. Pawlowski, Sonja Dorner, Franziska Hoffgaard, Bernhard Rössler, Dominik Maurer, Toni Weinschenk, Carsten Reinhardt, Christoph Huber, Hans-Georg Rammensee, Harpreet Singh‐Jasuja, Uğur Şahin, Pierre-Yves Dietrich, Wolfgang Wick - Nature 2018 被引用: 941

  5. Mutant MHC class II epitopes drive therapeutic immune responses to cancer

    著者: Sebastian Kreiter, Mathias Vormehr, Niels van de Roemer, Mustafa Diken, Martin Löwer, Jan Diekmann, Sebastian Boegel, Barbara Schrörs, Fulvia Vascotto, John C. Castle, Arbel D. Tadmor, Stephen P. Schoenberger, Christoph Huber, Özlem Türeci, Uğur Şahin - Nature 2015 被引用: 1,261

  6. Claudin-18 Splice Variant 2 Is a Pan-Cancer Target Suitable for Therapeutic Antibody Development

    著者: Uğur Şahin, Michael Koslowski, Karl Dhaene, Dirk Usener, Gunda Brandenburg, Gerhard Seitz, Christoph Huber, Özlem Türeci - Clinical Cancer Research 2008 被引用: 471

  7. FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinoma

    著者: Uğur Şahin, Ö. Türeci, Georgy M. Manikhas, Florian Lordick, Andriy Rusyn, Ihor Vynnychenko, Assen Dudov, I. Bazin, Igor Bondarenko, Bohuslav Melichar, Karl Dhaene, Kai Wiechen, Christoph Huber, Daniel Maurus, Ahsan M. Arozullah, J.W. Park, Martin Schüler, S. Al-Batran - Annals of Oncology 2021 被引用: 359

  8. Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells

    著者: Silke Holtkamp, Sebastian Kreiter, Abderraouf Selmi, Petra Simon, Michael Koslowski, Christoph Huber, Özlem Türeci, Uğur Şahin - Blood 2006 被引用: 610

  9. Exploiting the Mutanome for Tumor Vaccination

    著者: John C. Castle, Sebastian Kreiter, Jan Diekmann, Martin Löwer, Niels van de Roemer, Jos de Graaf, Abderraouf Selmi, Mustafa Diken, Sebastian Boegel, Claudia Paret, Michael Koslowski, Andreas N. Kuhn, Cedrik M. Britten, Christoph Huber, Özlem Türeci, Uğur Şahin - Cancer Research 2012 被引用: 826

  10. A multicentre, phase IIa study of zolbetuximab as a single agent in patients with recurrent or refractory advanced adenocarcinoma of the stomach or lower oesophagus: the MONO study

    著者: Ö. Türeci, Uğur Şahin, Henning Schulze‐Bergkamen, Zanete Zvirbule, Florian Lordick, Dieter Koeberle, Peter Thuss‐Patience, Thomas J. Ettrich, Dirk Arnold, Florian Bassermann, S-E. Al-Batran, Kai Wiechen, Karl Dhaene, Daniel Maurus, Michael A. Gold, Christoph Huber, Andrew Krivoshik, Ahsan M. Arozullah, J.W. Park, Martin Schüler - Annals of Oncology 2019 被引用: 244

  11. Therapeutic vaccines for cancer: an overview of clinical trials

    著者: Ignacio Melero, Gustav Gaudernack, Winald R. Gerritsen, Christoph Huber, Giorgio Parmiani, Suzy Scholl, Nicholas Thatcher, John Wagstaff, Christoph Zielinski, Ian Faulkner, Håkan Mellstedt - Nature Reviews Clinical Oncology 2014 被引用: 766

  12. A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer

    著者: Uğur Şahin, Martin Schüler, Heike Richly, Stefan Bauer, Anna Krilova, Tobias Dechow, Markus Jerling, Magdalena Utsch, Christoph Rohde, Karl Dhaene, Christoph Huber, Özlem Türeci - European Journal of Cancer 2018 被引用: 164

  13. Increased Antigen Presentation Efficiency by Coupling Antigens to MHC Class I Trafficking Signals

    著者: Sebastian Kreiter, Abderraouf Selmi, Mustafa Diken, Martin Sebastian, Phillip Osterloh, Hansjörg Schild, Christoph Huber, Özlem Türeci, Uğur Şahin - The Journal of Immunology 2008 被引用: 219

  14. Cancer classification using the Immunoscore: a worldwide task force

    著者: Jérôme Galon, Franck Pagès, Francesco M. Marincola, Helen K. Angell, Magdalena Thurin, Alessandro Lugli, Inti Zlobec, Anne Berger, Carlo Bifulco, Gerardo Botti, Fabiana Tatangelo, Cedrik M. Britten, Sebastian Kreiter, Lotfi Chouchane, Paolo Delrio, Hartmann Arndt, Martin Asslaber, Michele Maio, Giuseppe Masucci, Martin Mihm, Fernando Vidal‐Vanaclocha, James P. Allison, Sacha Gnjatic, Leif Håkansson, Christoph Huber, Harpreet Singh‐Jasuja, Christian H. Ottensmeier, H. Zwierzina, Luigi Laghi, Fabio Grizzi, Pamela S. Ohashi, Patricia A. Shaw, Blaise Clarke, Bradly G. Wouters, Yutaka Kawakami, Shoichi Hazama, Kiyotaka Okuno, Ena Wang, Jill O’Donnell-Tormey, Christine Lagorce, Graham Pawelec, Michael I. Nishimura, Robert D. Hawkins, Réjean Lapointe, Andreas Lundqvist, Samir N. Khleif, Shuji Ogino, Peter Gibbs, Paul Waring, Noriyuki Sato, Toshihiko Torigoe, Kyogo Itoh, Prabhudas S. Patel, Shilin N. Shukla, Richard Palmqvist, Irıs D. Nagtegaal, Yili Wang, Corrado D’Arrigo, Scott Kopetz, Frank A. Sinicrope, Giorgio Trinchieri, Thomas F. Gajewski, Paolo A. Ascierto, Bernard A. Fox - Journal of Translational Medicine 2012 被引用: 803

  15. Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity

    著者: Sebastian Kreiter, Abderraouf Selmi, Mustafa Diken, Michael Koslowski, Cedrik M. Britten, Christoph Huber, Özlem Türeci, Uğur Şahin - Cancer Research 2010 被引用: 307

  16. PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing

    著者: Amanda L. Gavin, Deli Huang, Christoph Huber, Annica Mårtensson, Virginie Tardif, Patrick Skog, Tanya R. Blane, T Thinnes, Kent G. Osborn, Hayley S. Chong, Farnaz Kargaran, Phoebe Kimm, Armen Zeitjian, Rachel L. Sielski, Megan Briggs, Sebastian Schulz, Alessandro Zarpellon, Benjamin F. Cravatt, Ee Shan Pang, John R. Teijaro, Juan Carlos de la Torre, Meredith O’Keeffe, Hubertus Hochrein, Markus Daμμe, Luc Teyton, Brian R. Lawson, David Nemazee - Nature Immunology 2018 被引用: 149

  17. Infective Endocarditis After Transcatheter Aortic Valve Replacement

    著者: Stefan Stortecky, Dik Heg, David Tueller, Thomas Pilgrim, Olivier Müller, Stéphane Noble, Raban Jeger, Stefan Toggweiler, Enrico Ferrari, Maurizio Taramasso, Francesco Maisano, Rebeca Hoeller, Peter Wenaweser, Fabian Nietlispach, Andreas F. Widmer, Christoph Huber, Marco Roffi, Thierry Carrel, Stephan Windecker, Anna Conen - Journal of the American College of Cardiology 2020 被引用: 111

  18. The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

    著者: Volker Lennerz, Martina Fatho, Chiara Gentilini, Roy A. Frye, Alexander Lifke, Dorothea Ferel, Catherine Wölfel, Christoph Huber, Thomas Wölfel - National Academy of Sciences, Proceedings of the National Academy of Sciences 2005 被引用: 451

  19. Temporal trends in adoption and outcomes of transcatheter aortic valve implantation: a SwissTAVI Registry analysis

    著者: Stefan Stortecky, Anna Franzone, Dik Heg, David Tueller, Stéphane Noble, Thomas Pilgrim, Raban Jeger, Stefan Toggweiler, Enrico Ferrari, Fabian Nietlispach, Maurizio Taramasso, Francesco Maisano, Jürg Grünenfelder, Olivier Müller, Christoph Huber, Marco Roffi, Thierry Carrel, Peter Wenaweser, Stephan Windecker - European Heart Journal - Quality of Care and Clinical Outcomes 2018 被引用: 94

  20. Serum levels of cytokines in chronic liver diseases

    著者: Herbert Tilg, Axel Wilmer, Wolfgang Vogel, Manfred Herold, Birgit Nölchen, Gert Judmaier, Christoph Huber - Gastroenterology 1992 被引用: 747

  21. The first batteryless, solar-powered cardiac pacemaker

    著者: Andreas Haeberlin, Adrian Zurbuchen, Sébastien Walpen, Jakob Schaerer, Thomas Niederhäuser, Christoph Huber, Hildegard Tanner, Helge Servatius, Jens Seiler, H. Haeberlin, Juerg Fuhrer, Rolf Vogel - Heart Rhythm 2015 被引用: 115

  22. Targeting the Heterogeneity of Cancer with Individualized Neoepitope Vaccines

    著者: Özlem Türeci, Mathias Vormehr, Mustafa Diken, Sebastian Kreiter, Christoph Huber, Uğur Şahin - Clinical Cancer Research 2016 被引用: 142

  23. Age-Related Outcomes After Transcatheter Aortic Valve Replacement

    著者: Adrian Attinger‐Toller, Enrico Ferrari, David Tueller, Christian Templin, Olivier Müller, Fabian Nietlispach, Stefan Toggweiler, Stéphane Noble, Marco Roffi, Raban Jeger, Christoph Huber, Thierry Carrel, Thomas Pilgrim, Peter Wenaweser, Mario Togni, Stéphane Cook, Dik Heg, Stephan Windecker, Jean‐Jácques Goy, Stefan Stortecky - JACC: Cardiovascular Interventions 2021 被引用: 72

  24. Coronary artery disease severity and aortic stenosis: clinical outcomes according to SYNTAX score in patients undergoing transcatheter aortic valve implantation

    著者: Giulio Stefanini, Stefan Stortecky, Davide Cao, Julie Rat-Wirtzler, Cróchán J. O’Sullivan, Steffen Gloekler, Lutz Buellesfeld, Ahmed A. Khattab, Fabian Nietlispach, Thomas Pilgrim, Christoph Huber, Thierry Carrel, Bernhard Meier, Peter Jüni, Peter Wenaweser, Stephan Windecker - European Heart Journal 2014 被引用: 185